Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

OptimizeRx (OPRX) EBT Margin: 2009-2024

Historic EBT Margin for OptimizeRx (OPRX) over the last 16 years, with FY2024 value amounting to 21.04%.

  • OptimizeRx's EBT Margin rose 506800.0% to 4.02% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.54%, marking a year-over-year increase of 393400.0%. This contributed to the annual value of 21.04% for FY2024, which is 141400.0% up from last year.
  • Per OptimizeRx's latest filing, its EBT Margin stood at 21.04% for FY2024, which was up 141400.0% from 35.18% recorded in FY2023.
  • OptimizeRx's 5-year EBT Margin high stood at 0.62% for FY2021, and its period low was 35.18% during FY2023.
  • For the 5-year period, OptimizeRx's EBT Margin averaged around 15.8%, with its median value being 18.32% (2022).
  • As far as peak fluctuations go, OptimizeRx's EBT Margin crashed by -189300bps in 2022, and later surged by 141400bps in 2024.
  • Over the past 5 years, OptimizeRx's EBT Margin (Annual) stood at 5.1% in 2020, then surged by 112bps to 0.62% in 2021, then tumbled by -3069bps to 18.32% in 2022, then plummeted by -92bps to 35.18% in 2023, then skyrocketed by 40bps to 21.04% in 2024.
  • Its EBT Margin was 21.04% in FY2024, compared to 35.18% in FY2023 and 18.32% in FY2022.